Anti-Inflammatory Milk Matrix

Description

Obesity is pro-inflammatory, impairs metabolism, and physically limiting. Specifically, muscle in obese persons does not synthesize proteins normally. This further increases metabolic and physical dysfunction. As such, obesity programs should not only focus on weight loss, but muscle metabolic health. Dairy nutrients have anti-inflammatory and anabolic properties, but mostly evaluated in isolation and/or pre-clinical designs. Also, it is unknown if the circulating benefits extend to the muscle. We hypothesize that dairy full-fat milk will improve these obesity characteristics.

Conditions

Obesity, Skeletal Muscle, Inflammation

Talk to us

Study Overview

On this page

Study Details

Study overview

Obesity is pro-inflammatory, impairs metabolism, and physically limiting. Specifically, muscle in obese persons does not synthesize proteins normally. This further increases metabolic and physical dysfunction. As such, obesity programs should not only focus on weight loss, but muscle metabolic health. Dairy nutrients have anti-inflammatory and anabolic properties, but mostly evaluated in isolation and/or pre-clinical designs. Also, it is unknown if the circulating benefits extend to the muscle. We hypothesize that dairy full-fat milk will improve these obesity characteristics.

Dairy Food Consumption and Its Effects on Inflammation and the Postprandial Regulation of Muscle Protein Synthesis

Anti-Inflammatory Milk Matrix

Condition
Obesity
Intervention / Treatment

-

Contacts and Locations

Urbana

Freer Hall, Urbana, Illinois, United States, 61801

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Obese (BMI, body mass index ≥30, \<40 kg•m-2)
  • * Age 40-59
  • * Pre-menopausal
  • * Sedentary/insufficiently active for prior 6 months (mo)
  • * Weight stable for prior 6 mo
  • * Tobacco, nicotine (patch/gum) use (previous 6 mo)
  • * Alcohol consumption \>10 drinks per week
  • * Metabolic disorders (e.g., Metabolic Syndrome, Diabetes, thyroid diseases)
  • * Cardiovascular disease, arrhythmias
  • * Hypogonadism
  • * Asthma
  • * History of uncontrolled hypertension
  • * Orthopedic injury/surgery (within 1 yr)
  • * Hepatorenal, musculoskeletal, autoimmune, or neurological disease
  • * History of neuromuscular problems
  • * Previous participation in amino acid tracer studies
  • * Predisposition to hypertrophic scarring or keloid formation
  • * Consumption of ergogenic-levels of dietary supplements that may affect muscle mass (e.g., creatine, HMB), insulin-like substances, or anabolic/catabolic pro-hormones (e.g., DHEA) within 6 weeks prior to participation
  • * Consumption of thyroid, androgenic, or other medications known to affect endocrine function
  • * Consumption of medications known to affect protein metabolism (e.g., prescription-strength corticosteroids, non-steroidal anti-inflammatories, or acne medication)
  • * Pregnancy
  • * Allergy to dairy product or lactose intolerance
  • * Fasting plasma glucose (FPG) ≥ 126 mg/dL
  • * Oral glucose tolerance test (OGTT) ≥ 200 mg/dL

Ages Eligible for Study

40 Years to 59 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Illinois at Urbana-Champaign,

Study Record Dates

2024-03